Novo Nordisk (NYSE:NVO) is preparing to release its quarterly earnings on Wednesday, 2026-02-04. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Novo Nordisk to report an earnings per share (EPS) of $0.89.

The market awaits Novo Nordisk's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Earnings History Snapshot

Last quarter the company beat EPS by $0.26, which was followed by a 4.02% drop in the share price the next day.

Here's a look at Novo Nordisk's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.770	0.93	0.90	0.83
EPS Actual	1.027	0.91	0.92	0.91
Price Change %	-4.000	7.00	-4.00	2.00

Performance of Novo Nordisk Shares

Shares of Novo Nordisk were trading at $58.93 as of February 02. Over the last 52-week period, shares are down 32.0%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Novo Nordisk visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.